• Je něco špatně v tomto záznamu ?

The labeling of unsaturated γ-hydroxybutyric acid by heavy isotopes of hydrogen: iridium complex-mediated H/D exchange by C─H bond activation vs reduction by boro-deuterides/tritides

A. Marek, MH. Pedersen, SB. Vogensen, RP. Clausen, B. Frølund, T. Elbert,

. 2016 ; 59 (12) : 476-483. [pub] 20160904

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc18017066

3-Hydroxycyclopent-1-ene-1-carboxylic acid (HOCPCA (1)) is a potent ligand for high-affinity γ-hydroxybutyric acid binding sites in the central nervous system. Various approaches to the introduction of a hydrogen label onto the HOCPCA skeleton are reported. The outcomes of the feasible C─H activation of olefin carbon (C-2) by iridium catalyst are compared with the reduction of the carbonyl group (C-3) by freshly prepared borodeuterides. The most efficient iridium catalysts proved to be Kerr bulky phosphine N-heterocyclic species providing outstanding deuterium enrichment (up to 91%) in a short period of time. The highest deuterium enrichment (>99%) was achieved through the reduction of ketone precursor 2 by lithium trimethoxyborodeuteride. Hence, analogical conditions were used for the tritiation experiment. [3 H]-HOCPCA selectively labeled on the position C-3 was synthetized with radiochemical purity >99%, an isolated yield of 637 mCi and specific activity = 28.9 Ci/mmol.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18017066
003      
CZ-PrNML
005      
20180516135639.0
007      
ta
008      
180515s2016 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/jlcr.3432 $2 doi
035    __
$a (PubMed)27593893
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Marek, Aleš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, v.v.i., Flemingovo nám. 2, Prague 6, 16610, Czech Republic. marek@uochb.cas.cz. Center for Nuclear Technologies, DTU Nutech/Hevesy Laboratory, Technical University of Denmark, Frederiksborgvej 399, Building 202, Roskilde, 4000, Denmark. marek@uochb.cas.cz.
245    14
$a The labeling of unsaturated γ-hydroxybutyric acid by heavy isotopes of hydrogen: iridium complex-mediated H/D exchange by C─H bond activation vs reduction by boro-deuterides/tritides / $c A. Marek, MH. Pedersen, SB. Vogensen, RP. Clausen, B. Frølund, T. Elbert,
520    9_
$a 3-Hydroxycyclopent-1-ene-1-carboxylic acid (HOCPCA (1)) is a potent ligand for high-affinity γ-hydroxybutyric acid binding sites in the central nervous system. Various approaches to the introduction of a hydrogen label onto the HOCPCA skeleton are reported. The outcomes of the feasible C─H activation of olefin carbon (C-2) by iridium catalyst are compared with the reduction of the carbonyl group (C-3) by freshly prepared borodeuterides. The most efficient iridium catalysts proved to be Kerr bulky phosphine N-heterocyclic species providing outstanding deuterium enrichment (up to 91%) in a short period of time. The highest deuterium enrichment (>99%) was achieved through the reduction of ketone precursor 2 by lithium trimethoxyborodeuteride. Hence, analogical conditions were used for the tritiation experiment. [3 H]-HOCPCA selectively labeled on the position C-3 was synthetized with radiochemical purity >99%, an isolated yield of 637 mCi and specific activity = 28.9 Ci/mmol.
650    _2
$a alkeny $x chemie $7 D000475
650    _2
$a bor $x chemie $7 D001895
650    _2
$a katalýza $7 D002384
650    _2
$a deuterium $x chemie $7 D003903
650    12
$a vodík-deuteriová výměna $7 D041961
650    _2
$a hydroxybutyráty $x chemie $7 D006885
650    _2
$a iridium $x chemie $7 D007495
650    _2
$a izotopové značení $7 D007553
650    _2
$a ligandy $7 D008024
650    _2
$a oxidace-redukce $7 D010084
650    _2
$a tritium $x chemie $7 D014316
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pedersen, Martin H F $u Center for Nuclear Technologies, DTU Nutech/Hevesy Laboratory, Technical University of Denmark, Frederiksborgvej 399, Building 202, Roskilde, 4000, Denmark.
700    1_
$a Vogensen, Stine B $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
700    1_
$a Clausen, Rasmus P $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
700    1_
$a Frølund, Bente $u Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, 2100, Copenhagen, Denmark.
700    1_
$a Elbert, Tomáš $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, v.v.i., Flemingovo nám. 2, Prague 6, 16610, Czech Republic.
773    0_
$w MED00002760 $t Journal of labelled compounds & radiopharmaceuticals $x 1099-1344 $g Roč. 59, č. 12 (2016), s. 476-483
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27593893 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20180516135815 $b ABA008
999    __
$a ok $b bmc $g 1300690 $s 1013906
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 59 $c 12 $d 476-483 $e 20160904 $i 1099-1344 $m Journal of labelled compounds & radiopharmaceuticals $n J Labelled Comp Radiopharm $x MED00002760
LZP    __
$a Pubmed-20180515

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...